Papers
3
Total Citations
15
H-Index
2
About
Dr. Megan Prunty is a rising urologic surgeon and researcher whose work centers on optimizing surgical outcomes and cost-effectiveness in major urologic oncology procedures. Her primary research areas include robotic-assisted surgery for renal cell carcinoma, particularly complex cases involving inferior vena cava thrombectomy, as well as the economic and clinical implications of perioperative resource utilization. Dr. Prunty’s most cited work, a comprehensive review of robotic-assisted radical nephrectomy with IVC thrombectomy (11 citations), provides critical insights into a technically demanding procedure, helping to standardize approaches and improve patient safety. She has also made notable contributions to understanding the financial landscape of urologic surgery, including a cost-effectiveness analysis of arterial catheter use during robotic-assisted laparoscopic prostatectomy and a study on national trends and predictors of local hemostatic agent use in major urologic procedures. These investigations, leveraging large databases like Premier Healthcare, highlight her commitment to evidence-based, value-driven care. Dr. Prunty’s research is particularly valuable for trainees and clinicians seeking to balance surgical innovation with fiscal responsibility, establishing her as a thoughtful voice in the future of urologic practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3